Company Search:
Advanced Search
Sponsored Links
Valneva SE Company Snapshot
Valneva SE operates within the Medicinals and botanicals sector. In addition to historical fundamental analyses, the complete report available to purchase compares Valneva SE with three other pharmaceutical manufacturers in Europe: Lavipharm SA of Greece (2015 sales of 26.37 million Euro [US$27.96 million] ), Horizon Discovery Group PLC of the United Kingdom (£20.16 million [US$24.28 million] of which 60% was Services), and Moberg Pharma AB (publ) which is based in Sweden (285.57 million Swedish Kronor [US$31.90 million] of which 55% was Nalox/Kerasal Nail, Sales of prodcuts).

Sales Analysis. During the year ended December of 2015, sales at Valneva SE were 78.36 million Euro (US$83.10 million). This is an increase of 112.2% versus 2014, when the company's sales were 36.92 million Euro. This was the third consecutive year of growth at Valneva SE. Sales of Technologies and Services saw an increase of 148.5% in 2015, from 5.07 million Euro to 12.59 million Euro. Not all segments of Valneva SE experienced an increase in sales in 2015: sales of Vaccine Candidates fell 4.2% to 8.69 million Euro.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Valneva SE
  Stock Performance Chart for Valneva SE
  Stock Data: Recent Stock Performance:
  Current Price (1/13/2017): 3.03
(Figures in Euro)
1 Week -2.9%   13 Weeks 3.8%  
4 Weeks 17.4%   52 Weeks -4.1%  
Valneva SE Key Data:
  Ticker: VLA Country: France
  Exchanges: PAR Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Medicinals & Botanicals
  2015 Sales 78,360,000
(Year Ending Jan 2016).
Employees: 390
  Currency: Euro Market Cap: 226,338,494
  Fiscal Yr Ends: December Shares Outstanding: 74,699,173
  Share Type: Actions Ordinaires Closely Held Shares: 13,866,760
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.